Febuxostat-aloperine co-amorphous drug delivery system with enhanced water solubility and binding affinity to xanthine oxidase.

Febuxostat (FEB), a primary long-term therapy for managing gout and chronic hyperuricaemia, has limited clinical application primarily due to its low aqueous solubility. This limitation necessitates high-dose administration, thereby increasing the ri…

Preview only. Read the full abstract at the source